ESR1 and breast cancer: Further unpublished observations showed that using an equivalent setup of fibroblasts but co-cultured with ERα-negative breast cancer cells, cell growth was reduced upon TGFβ inhibition, signifying a switch to a more pro-tumorigenic role of TGFβ which was in contrast to the studies using ERα-positive breast cancer cells.